Compare HCA Health Inc (HCA) vs Kinross Gold Corporation (KGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Kinross Gold Corporation — how do they compare? HCA Health Inc trades at $373.29 (market cap $82.17B), while Kinross Gold Corporation trades at $23.52 (market cap $26.63B). The key difference: HCA Health Inc is far larger — about 3.1× Kinross Gold Corporation's market cap, and HCA Health Inc pays the higher dividend (0.84%). Which is the better fit depends on your goals.
| HCA | KGC | |
|---|---|---|
Market Cap | $82.17B | $26.63B |
Sector | Health | Basic Materials |
52-Week High | $545.13 | $38.06 |
52-Week Low | $334.32 | $15.42 |
Enterprise Value | $131.08B | $25.18B |
Dividend Yield | 0.84% | 0.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $373.09, up 0.51% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 preliminary revenue above expectations but cut full-year profit guidance, causing recent stock pressure. Analyst consensus remains bullish with a $469.40 price target, though multiple law firms are investigating potential securities law violations following the guidance revision.
Investment outlook balances strong operational performance against near-term headwinds. The stock offers value with a 12.76 P/E ratio and consistent earnings beats, but faces risks from rising expenses, payer mix challenges, and ongoing legal investigations. Institutional sentiment remains positive despite technical weakness and recent guidance concerns.
Kinross Gold (KGC) trades at $23.43, up 3.79% on the day, with strong fundamentals including a P/E of 9.59 and robust profitability metrics. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 results due July 29, 2026. Technical indicators show bearish momentum despite oversold RSI conditions, while analyst consensus remains strongly bullish with a $37.20 price target representing 59% upside potential.
KGC presents a compelling value opportunity with attractive valuation multiples and strong cash flow generation. Key risks include gold price volatility and rising operational costs. The stock's current discount to analyst targets and improving financial trajectory suggest potential for significant appreciation, though investors should monitor Q2 earnings and gold market dynamics closely.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Kinross Gold Corporation
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →
